BerandaRUBICON • NSE
add
Rubicon Research Ltd
Tutup sebelumnya
₹782,10
Rentang hari
₹765,20 - ₹780,00
Rentang tahun
₹570,75 - ₹822,00
Kapitalisasi pasar
127,68 M INR
Volume Rata-Rata
145,18 rb
Rasio P/E
59,30
Hasil dividen
-
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (INR) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 4,76 M | 51,73% |
Biaya operasional | 2,22 M | 43,88% |
Penghasilan bersih | 727,97 jt | 91,20% |
Margin laba bersih | 15,31 | 26,01% |
Penghasilan per saham | 4,41 | — |
EBITDA | 1,12 M | 70,15% |
Tarif pajak efektif | 19,64% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,51 M | — |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 6,47 M | — |
Saham yang beredar | 163,22 jt | — |
Harga terhadap nilai buku | 18,64 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 19,87% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 727,97 jt | 91,20% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
Didirikan
1999
Situs
Karyawan
1.141
